4.7 Article

Optimizing antiviral therapy for COVID-19 with learned pathogenic model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

Remdesivir for Adults With COVID-19 A Living Systematic Review for American College of Physicians Practice Points

Timothy J. Wilt et al.

Summary: The study found that remdesivir may improve recovery and reduce mortality in severe COVID-19 patients compared to placebo. Among hospitalized patients, a 5-day course of remdesivir may provide similar benefits to a 10-day course with fewer side effects.

ANNALS OF INTERNAL MEDICINE (2021)

Review Pharmacology & Pharmacy

Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications

Jaykaran Charan et al.

Summary: The study found that remdesivir has potential in managing COVID-19 patients, but there are concerns about its effectiveness and the need to monitor liver and kidney function in patients. Recent data from WHO VigiBase (R) showed that the majority of ADEs involved COVID-19 patients, with a considerable proportion of patients from the Americas.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2021)

Article Multidisciplinary Sciences

In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness

Ruian Ke et al.

Summary: The study developed viral dynamic models of SARS-CoV-2 infection and established a model linking viral load (VL) to infectiousness. The analysis showed that VL in the upper respiratory tract is a better surrogate of infectiousness. Furthermore, RT-PCR tests performed better in detecting infection and preventing transmission, but more frequent antigen testing could provide similar results at a lower cost.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver Cirrhosis

Patricia Saunders-Hao et al.

Open Forum Infectious Diseases (2021)

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Article Virology

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned

Lars Dolken et al.

Summary: After more than one year of the COVID-19 pandemic, antiviral treatment options remain limited. Despite some clinical efficacy in individual cases, major trials have failed to confirm the effectiveness of antiviral drugs like remdesivir. Suggestions for improving future clinical trials and responses to pandemics are discussed.

VIRUSES-BASEL (2021)

Article Microbiology

In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2

Agnieszka M. Szemiel et al.

Summary: This study selected drug-resistant SARS-CoV-2 populations with decreased sensitivity to remdesivir (RDV) in vitro, identifying a mutation in NSP12 that decreases RDV sensitivity. There is no evidence of widespread transmission of RDV-resistant mutants among globally circulating SARS-CoV-2 variants. Additionally, emerging SARS-CoV-2 variants showed substitutions at Spike sites corresponding to those identified in vitro, indicating their potential to arise without immune selection.

PLOS PATHOGENS (2021)

Editorial Material Medicine, General & Internal

Connecting With Patients-The Missing Links

Lisa Sanders et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Infectious Diseases

Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19

Tianmin Xu et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Infectious Diseases

Early dynamics of transmission and control of COVID-19: a mathematical modelling study

Adam J. Kucharski et al.

LANCET INFECTIOUS DISEASES (2020)

Letter Critical Care Medicine

COVID-19 cytokine storm: the interplay between inflammation and coagulation

Ricardo J. Jose et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Medicine, General & Internal

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Engineering, Electrical & Electronic

How control theory can help us control Covid-19

Greg Stewart et al.

IEEE SPECTRUM (2020)

Article Infectious Diseases

The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics

Marco Siccardi et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Review Automation & Control Systems

In-host Mathematical Modelling of COVID-19 in Humans

Esteban A. Hernandez-Vargas et al.

ANNUAL REVIEWS IN CONTROL (2020)

Editorial Material Medicine, Research & Experimental

Safety profile of the antiviral drug remdesivir: An update

Qianqian Fan et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Proceedings Paper Engineering, Multidisciplinary

Stabilizing COVID-19 Infections in US by Feedback Control based Test and Quarantine

Abhishek Dutta

2020 IEEE GLOBAL HUMANITARIAN TECHNOLOGY CONFERENCE (GHTC) (2020)

Article Immunology

T cell responses in patients with COVID-19

Zeyu Chen et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Cell Biology

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Biochemistry & Molecular Biology

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

Vineet D. Menachery et al.

NATURE MEDICINE (2015)

Review Virology

Modeling Influenza Virus Infection: A Roadmap for Influenza Research

Alessandro Boianelli et al.

VIRUSES-BASEL (2015)

Review Biology

Modeling the within-host dynamics of HIV infection

Alan S. Perelson et al.

BMC BIOLOGY (2013)

Article Computer Science, Interdisciplinary Applications

Multi-objective multi-drug scheduling schemes for cell cycle specific cancer treatment

M. S. Alam et al.

COMPUTERS & CHEMICAL ENGINEERING (2013)

Article Operations Research & Management Science

Implementing the Nelder-Mead simplex algorithm with adaptive parameters

Fuchang Gao et al.

COMPUTATIONAL OPTIMIZATION AND APPLICATIONS (2012)

Article Chemistry, Multidisciplinary

Systems Pharmacology: Bridging Systems Biology and Pharmacokinetics-Pharmacodynamics (PKPD) in Drug Discovery and Development

Piet H. van der Graaf et al.

PHARMACEUTICAL RESEARCH (2011)

Article Engineering, Biomedical

Control of the HIV infection and drug dosage

Marie-Jose Mhawej et al.

BIOMEDICAL SIGNAL PROCESSING AND CONTROL (2010)

Review Immunology

Modelling viral and immune system dynamics

AS Perelson

NATURE REVIEWS IMMUNOLOGY (2002)